NCT04090294 Assessment of Early Outcomes of Roflumilast in Patients With Non Cystic Fibrosis Bronchiectasis Status UNKNOWN Phase EARLY_PHASE1
NCT04069312 Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE) Status COMPLETED Phase PHASE4
NCT03988816 Effect of Roflumilast on Quality of Life, Lung Function and Mucus Properties in Patients With Bronchiectasis Status UNKNOWN Phase PHASE2
NCT03764475 Long-Term Safety of ARQ-151 Cream in Adult Subjects With Chronic Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT03458546 Study of Roflumilast in Combination With Standard Chemotherapy for High-risk Diffuse Large B-cell Lymphoma Status COMPLETED Phase PHASE1
NCT03073798 The Effectiveness of Roflumilast in Improving Mucociliary Clearance in Patients With COPD and Chronic Bronchitis Status COMPLETED Phase PHASE4
NCT02671942 A Multicenter Randomized Double-blind Clinical Study Evaluated the Safety, Pharmacokinetic and Pharmacodynamic Characteristics of Roflumilast in COPD Patients Status TERMINATED Phase PHASE2
NCT02451540 Evaluation of the Effect of Roflumilast in Hyperinflated COPD Patients Using Functional Respiratory Imaging Status TERMINATED Phase PHASE2
NCT02187250 PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome Status COMPLETED Phase PHASE4
NCT02165826 Evaluation of Tolerability and Pharmacokinetics of Roflumilast, 250μg and 500μg, as add-on to Standard COPD Treatment to Treat Severe COPD Status COMPLETED Phase PHASE3
NCT02097992 Effect of Roflumilast on Airway Blood Flow as an Expression of Airway Inflammation in COPD Status COMPLETED Phase PHASE1/PHASE2
NCT02079844 Roflumilast Plus Antipsychotics Proof of Mechanism Study in Schizophrenia Status COMPLETED Phase PHASE1
NCT02051335 Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy Adults Status COMPLETED Phase PHASE1
NCT01973998 Effects of Roflumilast in Hospitalized Chronic Obstructive Pulmonary Disease( COPD) on Mortality and Re-hospitalization Status COMPLETED Phase PHASE3
NCT01888952 Phase 0/1 Biomarker and Pharmacodynamic Study of Roflumilast in Patients With Advanced B-Cell Hematologic Malignancies (CTRC# 13-0013) Status COMPLETED Phase EARLY_PHASE1
NCT01862029 Effects of Roflumilast on Insulin and Blood Sugar Levels in Prediabetic Overweight and Obese Individuals Status COMPLETED Phase PHASE1/PHASE2